Abstract
The benefits of cholesterol-lowering with statins has been established for patients with high cholesterol levels as well as for patients with prior occlusive coronary heart disease. However; substantial uncertainty has existed about the long-term benefits of these agents in certain groups, including patients with “normal” cholesterol levels pretreatment, women, the elderly, as well as those with prior occlusive non-coronary disease. The Heart Protection Study 1 was designed to resolve these uncertainties and to provide substantially more safety information of statins. We present its significance and practical implications.
© 2004 Salam and Gehani, licensee Bloomsbury Qatar Foundation Journals.
Article metrics loading...
/content/journals/10.5339/qmj.2004.1.6
2004-06-01
2024-03-29
Full text loading...
References
-
Heart Protection Collaborative Study Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 individuals: A randomised placebo-controlled trial. Lancet. 2002; 360::7–22.
[Google Scholar]
-
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344::1383–1389.
[Google Scholar]
-
Shepherd J, Cobbe SM, Ford I, et al., Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995; 333::1301–1307.
[Google Scholar]
-
Sacks FM, Pfejfer MA, Moye LA, et al., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996; 335::1001–1009.
[Google Scholar]
-
Downs JR, Clearfield M, Weis S, et al., Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998; 279::1615–1622.
[Google Scholar]
-
The Long-Term Intervention With Pravastatin In Ischemic Disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998; 339::1349–1357.
[Google Scholar]
-
Salam AM. Expanding indications of statins; implications of the Heart Protection Study. Expert Opin Investig Drugs. 2003; 12::509–513.
[Google Scholar]
-
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final report. Circulation. 2002; 106:25:3143–3421.
[Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2004.1.6